AI and Healthcare Responsible AI Needs Global Regulation
Sep 29, 2025
Emily Lewis dives into the debate over whether AI in health records qualifies as a medical device, comparing regulatory approaches from the U.S. and U.K. She highlights the importance of balancing regulation with the need for flexible, responsible AI usage. With fragmented global guidelines, she emphasizes the necessity of local adaptation for effective implementation. Lewis also advocates for staying informed through daily news and podcasts, suggesting that AI has the potential to enhance human intelligence when utilized correctly.
AI Snips
Chapters
Transcript
Episode notes
Regulation Needs Foresight And Balance
- Rapid AI advancement demands foresighted regulation to avoid harm or stifling innovation.
- Regulation should balance not overregulating while ensuring responsible AI for patients.
Local Rules Create Global Ripples
- National stances will create ripple effects requiring tighter controls elsewhere.
- Companies must expect stricter rules when rolling products into conservative jurisdictions.
Divergent Global Definitions Matter
- Regulatory definitions for AI in health vary internationally and affect product classification.
- The NHS treats AI integrated into health records as a medical device, unlike current U.S. definitions.